Cargando…
Topical fibroblast growth factor‐2 for treatment of chronic tympanic membrane perforations
OBJECTIVE: To determine the efficacy of fibroblast growth factor‐2 (FGF‐2) in treating chronic nonhealing tympanic membrane (TM) perforations. METHOD: Double‐blinded, randomized placebo controlled phase 2 clinical trial for patients with chronic TM perforations of more than 3 months duration with a...
Autores principales: | Santos, Felipe, Shu, Edina, Lee, Daniel J., Jung, David H., Quesnel, Alicia M., Stankovic, Konstantina M., Abdul‐Aziz, Dunia E., Bay, Camden P., Quinkert, Amy, Welling, D. Bradley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444771/ https://www.ncbi.nlm.nih.gov/pubmed/32864435 http://dx.doi.org/10.1002/lio2.395 |
Ejemplares similares
-
Providing health care to patients with hearing loss during COVID‐19 and physical distancing
por: West, Jessica S., et al.
Publicado: (2020) -
Twelve‐month outcomes of a bioabsorbable implant for in‐office treatment of dynamic nasal valve collapse
por: Sidle, Douglas M., et al.
Publicado: (2019) -
IVORY Guidelines (Instructional Videos in Otorhinolaryngology by YO‐IFOS): A Consensus on Surgical Videos in Ear, Nose, and Throat
por: Simon, François, et al.
Publicado: (2020) -
In Reference to
COVID‐19 and the Otolaryngologist: Preliminary Evidence‐based Review
por: Baba, Yuh, et al.
Publicado: (2021) -
Long‐Term Stability and Safety of the Soundbridge Coupled to the Round Window
por: Sprinzl, Georg Mathias, et al.
Publicado: (2020)